Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$287K Buy
2,226
+213
+11% +$24.9K 0.14% 78
2026
Q1
$243K Buy
2,013
+41
+2% +$4.73K 0.13% 86
2025
Q4
$208K Sell
1,972
-4,578
-70% -$430K 0.11% 90
2025
Q3
$551K Buy
6,550
+111
+2% +$9.14K 0.21% 89
2025
Q2
$511K Sell
6,439
-1,186
-16% -$94.3K 0.2% 90
2025
Q1
$686K Sell
7,625
-611
-7% -$57K 0.28% 75
2024
Q4
$821K Sell
8,236
-149
-2% -$15.4K 0.32% 70
2024
Q3
$954K Buy
8,385
+111
+1% +$13.2K 0.38% 60
2024
Q2
$954K Buy
8,274
+12
+0.1% +$1.55K 0.41% 54
2024
Q1
$903K Hold
8,262
0.43% 43
2023
Q4
$903K Buy
+8,262
New +$858K 0.43% 43

Other funds holding MRK

Sachetta's MRK Position: Q2 2026 in Review

Sachetta increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $24.9K and bringing the position to 2,226 shares worth $287K. The position accounts for 0.14% of the portfolio, ranked #78.

Sachetta first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $954K in Q3 2024. 847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sachetta held 2,226 shares of Merck worth $287K as of Q2 2026.
  • Sachetta bought 213 Merck shares in Q2 2026, an estimated $24.9K.
  • Merck made up 0.14% of Sachetta's portfolio in Q2 2026, its #78 holding.
  • Sachetta first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Sachetta's Merck position peaked at $954K in Q3 2024.
  • 847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.